BioWorld

March 10, 2003

Congress Looking Into Law Requiring Trials For Children

WASHINGTON - Companies developing biologics that could be used off-label in children may end up having to run pediatric clinical trials. (BioWorld Today) Read More

Corus Raises $40M Privately For Phase II Asthma, CF Drugs

Lymphocytes Activate Plasma Cells To Generate Huge Antibody Quantities And Multiple Myeloma

Sopherion Gets $26M In Series A To Support Platforms, Pipeline

One-Man Company, Synergia, Gets $2M To Work On Migraine

Other News To Note

Correction

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...